Increased O-GlcNAc levels correlate with decreased O-GlcNAcase levels in Alzheimer disease brain

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1842, Issue 9, 2014, Pages 1333-1339

  Förster, Sarah ^a,b   Welleford, Andrew S ^b   Triplett, Judy C ^b   Sultana, Rukhsana ^b,d   Schmitz, Brigitte ^a   Butterfield, D Allan ^b,c  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF KENTUCKY   (United States)

^c UNIVERSITY OF KENTUCKY   (United States)

^d UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; O GlcNAc; O GlcNAcase

Indexed keywords

GLUCOSAMINE DERIVATIVE; N ACETYL BETA GLUCOSAMINIDASE; O LINKED N ACETYL BETA DEXTRO GLUCOSAMINE; O LINKED N ACETYL BETA DEXTRO GLUCOSAMINIDASE; UNCLASSIFIED DRUG;

AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN LEVEL; CEREBELLUM; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOSOLIC FRACTION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN TISSUE; INFERIOR PARIETAL LOBULE; MALE; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN MODIFICATION; VERY ELDERLY;

ALZHEIMER DISEASE; O-GLCNAC; O-GLCNACASE;

ACETYLGLUCOSAMINE; AGED, 80 AND OVER; ALZHEIMER DISEASE; BETA-N-ACETYLHEXOSAMINIDASES; BRAIN; CASE-CONTROL STUDIES; FEMALE; HUMANS; IMMUNOBLOTTING; MALE; N-ACETYLGLUCOSAMINYLTRANSFERASES; PROTEIN PROCESSING, POST-TRANSLATIONAL;

EID: 84903477779     PISSN: 09254439     EISSN: 1879260X     Source Type: Journal    
DOI: 10.1016/j.bbadis.2014.05.014     Document Type: Article

References (50)

1. Torres C.R., Hart G.W. Topography and polypeptide distribution of terminal N-acetylglucosamine residues on the surfaces of intact lymphocytes: Evidence for O-linked GlcNAc. J. Biol. Chem. 1984, 250:3308-3317.
2. Zachara N.E., O'Donnell N., Cheung W.D., Mercer J.J., Marth J.D., Hart G.W. Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells. J. Biol. Chem. 2004, 279:30133-30142.
3. Haltiwanger R.S., Holt G.D., Hart G.W. Enzymatic addition of O-GlcNAc to nuclear and cytoplasmic proteins. Identification of a uridine diphospho-N-acetylglucosamine:peptide beta-N-acetylglucosaminyltransferase. J. Biol. Chem. 1990, 265:2563-2568.
4. Kreppel L.K., Hart G.W. Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. J. Biol. Chem. 1999, 274:32015-32022.
5. Marshall S., Bacote V., Traxinger R.R. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system. Role of hexosamine biosynthesis in the induction of insulin resistance. J. Biol. Chem. 1991, 266:4706-4712.
6. Wells L., Vosseller K., Hart G.W. A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance. Cell. Mol. Life Sci. 2003, 60:222-228.
7. Dong D.L., Hart G.W. Purification and characterization of an O-GlcNAc selective N-acetyl-beta-D-glucosaminidase from rat spleen cytosol. J. Biol. Chem. 1994, 269:19321-19330.
8. Okuyama R., Marshall S. UDP-N-acetylglucosaminyl transferase (OGT) in brain tissue: Temperature sensitivity and subcellular distribution of cytosolic and nuclear enzyme. J. Neurochem. 2003, 86:1271-1280.
9. Gao Y., Wells L., Comer F.I., Parker G.J., Hart G.W. Dynamic O-glycosylation of nuclear and cytosolic proteins: Cloning and characterization of a neutral, cytosolic beta-N-acetylglucosaminidase from human brain. J. Biol. Chem. 2001, 276:9838-9845.
10. Shafi R., Iyer S.P., Ellies L.G., O'Donnell N., Marek K.W., Chui D., Hart G.W., Marth J.D. The O-GlcNAc transferase gene resides on the X chromosome and is essential for embryonic stem cell viability and mouse ontogeny. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:5735-5739.
11. Lubas W.A., Hanover J.A. Functional expression of O-linked GlcNAc transferase. Domain structure and substrate specificity. J. Biol. Chem. 2000, 275:10983-10988.
12. Hanover J.A., Yu S., Lubas W.B., Shin S.H., Ragano-Caracciola M., Kochran J., Love D.C. Mitochondrial and nucleocytoplasmic isoforms of O-linked GlcNAc transferase encoded by a single mammalian gene. Arch. Biochem. Biophys. 2003, 409:287-297.
13. Heckel D., Comtesse N., Brass N., Blin N., Zang K.D., Meese E. Novel immunogenic antigen homologous to hyaluronidase in meningioma. Hum. Mol. Genet. 1998, 7:1859-1872.
14. Comtesse N., Maldener E., Meese E. Identification of a nuclear variant of MGEA5, a cytoplasmic hyaluronidase and a beta-N-acetylglucosaminidase. Biochem. Biophys. Res. Commun. 2001, 283:634-640.
15. Yang Y.R., Song M., Lee H., Jeon Y., Choi E.J., Jang H.J., Moon H.Y., Byun H.Y., Kim E.K., Kim D.H., Lee M.N., Koh A., Ghim J., Choi J.H., Lee-Kwon W., Kim K.T., Ryu S.H., Suh P.G. O-GlcNAcase is essential for embryonic development and maintenance of genomic stability. Aging Cell 2012, 11:439-448. 10.1111/j.1474-9726.2012.00801.x.
16. Bond M.R., Hanover J.A. O-GlcNAc cycling: A link between metabolism and chronic disease. Annu. Rev. Nutr. 2013, 33:205-229. 10.1146/annurev-nutr-071812-161240.
17. Selkoe D.J. Alzheimer's disease: Genes, proteins, and therapy. Physiol. Rev. 2001, 81:741-766.
18. Heiss W.D., Szelies B., Kessler J., Herholz K. Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann. N. Y. Acad. Sci. 1991, 640:65-71.
19. Bertram L., Blacker D., Mullin K., Keeney D., Jones J., Basu S., Yhu S., McInnis M.G., Go R.C., Vekrellis K., Selkoe D.J., Saunders A.J., Tanzi R.E. Evidence for genetic linkage of Alzheimer's disease to chromosome 10q. Science 2000, 290:2302-2303.
20. Griffith L.S., Mathes M., Schmitz B. Beta-amyloid precursor protein is modified with O-linked N-acetylglucosamine. J. Neurosci. Res. 1995, 41:270-278.
21. Arnold C.S., Johnson G.V., Cole R.N., Dong D.L., Lee M., Hart G.W. The microtubule-associated protein tau is extensively modified with O-linked N-acetylglucosamine. J. Biol. Chem. 1996, 271:28741-28744.
22. Dong D.L., Xu Z.S., Chevrier M.R., Cotter R.J., Cleveland D.W., Hart G.W. Glycosylation of mammalian neurofilaments. Localization of multiple O-linked N-acetylglucosamine moieties on neurofilament polypeptides L and M. J. Biol. Chem. 1993, 268:16679-16687.
23. Griffith L.S., Schmitz B. O-Linked N-acetylglucosamine is upregulated in Alzheimer brains. Biochem. Biophys. Res. Commun. 1995, 213:424-431.
24. Liu F., Shi J., Tanimukai H., Gu J., Gu J., Grundke-Iqbal I., Iqbal K., Gong C.X. Reduced O-GlcNAcylation links lower brain glucose metabolism and tau pathology in Alzheimer's disease. Brain 2009, 132:1820-1832. 10.1093/brain/awp099.
25. Jacobs H.D., von Boxtel M.P.J., Jolles J., Verhey F.R.J., Uylings H.B.M. Parietal cortex matters in Alzheimer's disease: An overview of structural, functional and metabolic findings. Neurosci. Biobehav. Rev. 2012, 36:297-309.
26. Zachara N.E., Vosseller K., Hart G.W. Detection and analysis of proteins modified by O-linked N-acetylglucosamine. Curr. Protoc. Protein Sci. 2011, 66:12.8.1-12.8.33. 10.1002/0471140864.ps1208s66.
27. Cieniewski-Bernard C., Bastides B., Lefebvre T., Lemoine J., Mounier Y., Michalski J.C. Identification of O-linked N-acetylglucosamine proteins in rat skeletal muscle using two-dimensional gel electrophoresis and mass spectrometry. Mol. Cell. Proteomics 2004, 3:577-585.
28. Liu F., Iqbal K., Grundke-Iqbal I., Hart G.W., Gong C.X. O-GlcNAcylation regulates phosphorylation of tau: A mechanism involved in Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:10804-10809.
29. Liu Y., Liu F., Iqbal K., Grundke-Iqbal I., Gong C.X. Decreased glucose transporters correlate to abnormal hyperphosphorylation of tau in Alzheimer disease. FEBS Lett. 2008, 582:359-364. 10.1016/j.febslet.2007.12.035.
30. Kalaria R.N., Harik S.I. Reduced glucose transporter at the blood-brain barrier and in cerebral cortex in Alzheimer disease. J. Neurochem. 1989, 53:1083-1088.
31. Harr S.D., Simonian N.A., Hyman B.T. Functional alterations in Alzheimer's disease: Decreased glucose transporter 3 immunoreactivity in the perforant pathway terminal zone. J. Neuropathol. Exp. Neurol. 1995, 54:38-41.
32. Cheung W.D., Hart G.W. AMP-activated protein kinase and p38 MAPK activate O-GlcNAcylation of neuronal proteins during glucose deprivation. J. Biol. Chem. 2008, 283:13009-13020. 10.1074/jbc.M801222200.
33. Taylor R.P., Parker G.J., Hazel M.W., Soesanto Y., Fuller W., Yazzie M.J., McClain D.A. Glucose deprivation stimulates O-GlcNAc modification of proteins through up-regulation of O-linked N-acetylglucosaminyltransferase. J. Biol. Chem. 2008, 283:6050-6057. 10.1074/jbc.M707328200.
34. Zou L., Zhu-Mauldin X., Marchase R.B., Paterson A.J., Liu J., Yang Q., Chatham J.C. Glucose deprivation-induced increase in protein O-GlcNAcylation in cardiomyocytes is calcium-dependent. J. Biol. Chem. 2012, 287:34419-34431. 10.1074/jbc.M112.393207.
35. Sultana R., Perluigi M., Butterfield D.A. Protein oxidation and lipid peroxidation in brain of subjects with Alzheimer's disease: Insights into mechanism of neurodegeneration from redox proteomics. Antioxid. Redox Signal. 2006, 8:2021-2037.
36. Du X.L., Edelstein D., Rossetti L., Fantus I.G., Goldberg H., Ziyadeh F., Wu J., Brownlee M. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc. Natl. Acad. Sci. U. S. A. 2000, 97:12222-12226.
37. Sultana R., Poon H.F., Cai J., Pierce W.M., Merchant M., Klein J.B., Markesbery W.R., Butterfield D.A. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol. Dis. 2006, 22:76-87.
38. Butterfield D.A., Hardas S.S., Lange M.L. Oxidatively modified glyceraldehyde-3-phosphate dehydrogenase (GAPDH) and Alzheimer's disease: Many pathways to neurodegeneration. J. Alzheimers Dis. 2010, 20:369-393. 10.3233/JAD-2010-1375.
39. Liu Y., Li X., Yu Y., Shi J., Liang Z., Run X., Li Y., Dai C.L., Grundke-Iqbal I., Iqbal K., Liu F., Gong C.X. Developmental regulation of protein O-GlcNAcylation, O-GlcNAc transferase, and O-GlcNAcase in mammalian brain. PLoS One 2012, 7:e43724. 10.1371/journal.pone.0043724.
40. Kreppel L.K., Blomberg M.A., Hart G.W. Dynamic glycosylation of nuclear and cytosolic proteins. Cloning and characterization of a unique O-GlcNAc transferase with multiple tetratricopeptide repeats. J. Biol. Chem. 1997, 272:9308-9315.
41. Keembiyehetty C.N., Krzeslak A., Love D.C., Hanover J.A. A lipid-droplet-targeted O-GlcNAcase isoform is a key regulator of the proteasome. J. Cell Sci. 2011, 124:2851-2860. 10.1242/jcs.083287.
42. Kim E.J., Kang D.O., Love D.C., Hanover J.A. Enzymatic characterization of O-GlcNAcase isoforms using a fluorogenic GlcNAc substrate. Carbohydr. Res. 2006, 341:971-982.
43. Macauley M.S., Vocadlo D.J. Enzymatic characterization and inhibition of the nuclear variant of human O-GlcNAcase. Carbohydr. Res. 2009, 344:1079-1084.
44. Whisenhunt T.R., Yang X., Bowe D.B., Paterson A.J., van Tine B.A., Kudlow J.E. Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development. Glycobiology 2006, 16:551-563.
45. Lazarus B.D., Love D.C., Hanover J.A. Recombinant O-GlcNAc transferase isoforms: Identification of O-GlcNAcase, yes tyrosine kinase, and tau as isoform-specific substrates. Glycobiology 2006, 16:415-421.
46. Twine N.A., Janitz K., Wilkins M.R., Janitz M. Whole transcriptome sequencing reveals gene expression and splicing differences in brain regions affected by Alzheimer's disease. PLoS One 2011, 6:e16266.
47. Butkinaree C., Cheung W.D., Park S., Park K., Barber M., Hart G.W. Characterization of beta-N-acetylglucosaminidase cleavage by caspase-3 during apoptosis. J. Biol. Chem. 2008, 283:23557-23566.
48. Kim C., Nam D.W., Park S.Y., Song H., Hong H.S., Boo J.H., Jung E.S., Kim Y., Baek J.Y., Kim K.S., Cho J.W., Mook-Jung I. O-Linked β-N-acetylglucosaminidase inhibitor attenuates β-amyloid plaque and rescues memory impairment. Neurobiol. Aging 2013, 34:275-285. 10.1016/j.neurobiolaging.2012.03.001.
49. Yuzwa S.A., Shan X., Macauley M.S., Clark T., Skorobogatko Y., Vosseller K., Vocadlo D.J. Increasing O-GlcNAc slows neurodegeneration and stabilizes tau against aggregation. Nat. Chem. Biol. 2012, 8:393-399. 10.1038/nchembio.797.
50. Borghgraef P., Menuet C., Theunis C., Louis J.V., Devijver H., Marin H., Smet-Nocca C., Lippens G., Hillaire G., Gijsen H., Moechars D., van Leuven F. Increasing brain protein O-GlcNAcylation mitigates breathing defects and mortality of Tau.P301L mice. PLoS One 2013, 8:e84442. 10.1371/journal.pone.0084442.